Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real

Why This Matters

Anorectal malformations and Hirschsprung disease each occupy their own corner of pediatric surgery — one a structural defect present at birth, the other a motility disorder from absent ganglion cells 0:34. Most surgeons will never see them together in the same patient 0:34. But when a child with an ARM repair continues to struggle with bowel management despite appropriate intervention, the possibility of dual pathology becomes clinically relevant 0:37. This is particularly true when chromosomal anomalies are present 0:37.

The Clinical Problem

Anorectal malformations require surgical reconstruction, typically via posterior sagittal anorectoplasty (PSARP), which creates a functional anus from abnormal anatomy 0:41. After healing, these children enter a bowel management program — a combination of dietary modification, laxatives, and enemas designed to achieve social continence 1:31. Most respond. Some do not.

When a complex ARM patient fails standard bowel management, the differential includes inadequate surgical repair, persistent anatomic abnormality, neuropathic dysfunction, or behavioral factors 1:31. Hirschsprung disease — a condition where absent ganglion cells prevent coordinated peristalsis — is not typically high on that list 0:34. The co-occurrence rate is less than 2% 0:34. But dismissing it entirely in certain patients may be a mistake 0:37.

What the Evidence Shows

A single-center study examined rectal fistula tissue obtained during PSARP procedures 0:41. This tissue is not physiologic — it represents the abnormal connection between rectum and perineum or genitourinary tract that defines the malformation 0:52. The question was whether ganglion cells could be reliably identified in this tissue, and what their absence might mean 0:41.

Ganglion cells were present in 91% of specimens 0:58. The remaining 9% showed hypo- or absent ganglion cells 0:58. Critically, absent ganglion cells in fistula tissue does not establish a diagnosis of Hirschsprung disease 1:05. The tissue itself is abnormal, and the absence of ganglion cells may reflect the pathology of the fistula rather than a diffuse motility disorder 1:05.

But four percent of patients in this cohort — three children — did have both conditions confirmed 1:11. Two of those three also had trisomy 21 1:15. This pattern held across the broader literature: patients with both Hirschsprung disease and ARM tend to carry chromosomal anomalies, including trisomy 21, Pallister-Killian syndrome, and others 1:22 1:27.

The Clinical Framework

The practical takeaway is not that every ARM patient needs a rectal biopsy 1:31. It is that a specific subset — complex malformations, chromosomal anomalies, refractory bowel dysfunction — warrants a higher index of suspicion 1:31.

Complex ARM patients with chromosomal anomalies who do not respond to laxatives or enemas should be worked up for Hirschsprung disease 1:31. This means rectal biopsy from physiologic tissue, not fistula remnants 1:05. It means contrast enema looking for a transition zone 1:31. It means reconsidering the diagnosis when the clinical picture does not fit the expected post-operative course 1:31.

The risk of missing dual pathology is years of ineffective bowel management, repeated dilations, escalating interventions, and a family convinced their child's surgery failed when the real problem was never addressed 1:31. The risk of over-testing is a biopsy in a child who was already going to need anesthesia for other procedures 1:31.

Where Uncertainty Remains

This discussion does not resolve whether routine histologic examination of fistula tissue during PSARP is useful 0:41 1:05. The presence of ganglion cells in fistula tissue may be reassuring, but their absence is not diagnostic 1:05. The study establishes a baseline — most fistulas contain ganglion cells — but does not provide a decision rule 0:58 1:05.

It also does not define "refractory" bowel management with precision 1:31. How long should a trial of medical management last before pursuing further workup? What degree of response is adequate? These are judgment calls, informed by the severity of the malformation, the presence of associated anomalies, and the family's tolerance for ongoing intervention 1:31.

When to Involve Colorectal Surgery

Any ARM patient with persistent obstructive symptoms, severe constipation unresponsive to escalating medical therapy, or clinical features suggesting dysmotility should prompt reconsideration of the diagnosis 1:31. If a chromosomal anomaly is present — particularly trisomy 21 — the threshold for rectal biopsy should be lower 1:15 1:22 1:31. If the child is already under the care of a pediatric colorectal surgeon, this is a conversation within that relationship 1:31. If not, referral is appropriate when standard post-operative management is not achieving the expected result and dual pathology is a reasonable explanation 1:31.